Westhovens R
UZ Pellenberg, Division of Rheumatology, Belgium.
Clin Rheumatol. 1995 Sep;14 Suppl 2:19-21. doi: 10.1007/BF02215853.
As one proposes sometimes more aggressive immunomodulatory treatment early in the process of rheumatoid arthritis, it becomes necessary to think about the prognostic factors early in the disease process that can predict eventual later poor outcome. We summarize the literature of the last 10 years dealing with this topic.
随着有人提议在类风湿关节炎病程早期有时采用更积极的免疫调节治疗，有必要在疾病进程早期就考虑那些能够预测最终不良预后的预后因素。我们总结了过去10年中关于该主题的文献。
